200,000+ products from a single source!
sales@angenechem.com
Home > Quinoline > 101467-40-7
            CAS No: 101467-40-7 Catalog No: AG0004JP MDL No:
| Title | Journal | 
|---|---|
| Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. | Bioorganic & medicinal chemistry 20121115 | 
| Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated. | Neurotoxicity research 20111001 | 
| Chiral capillary electrophoresis-mass spectrometry of tetrahydroisoquinoline-derived neurotoxins: observation of complex stereoisomerism. | Journal of chromatography. A 20110520 | 
| Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells. | Neurotoxicity research 20091001 | 
| A new microdialysis-electrochemical device for in vivo simultaneous determination of acetylcholine and choline in rat brain treated with N-methyl-(R)-salsolinol. | Biosensors & bioelectronics 20090815 | 
| Quantification of salsolinol enantiomers by stable isotope dilution liquid chromatography with tandem mass spectrometric detection. | Rapid communications in mass spectrometry : RCM 20081201 | 
| Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells. | Neuroscience bulletin 20080601 | 
| N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2. | Journal of neural transmission (Vienna, Austria : 1996) 20060101 | 
| Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells. | Journal of neurochemistry 20060101 | 
| Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection. | Journal of neural transmission. Supplementum 20060101 | 
| Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells. | Life sciences 20040521 | 
| Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in Parkinsonian patients' cerebrospinal fluid. | The Analyst 20040301 | 
| Cell death in Parkinson's disease. | Journal of neurology 20020901 | 
| Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan. | Journal of neurochemistry 20020801 | 
| Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuroprotection by propargylamines. | Journal of neural transmission (Vienna, Austria : 1996) 20020501 | 
| Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. | Neurotoxicology and teratology 20020101 | 
| Future of neuroprotection in Parkinson's disease. | Parkinsonism & related disorders 20011001 | 
| Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. | Journal of neurochemistry 20010801 | 
| [Pathogenesis of idiopathic Parkinson's disease]. | Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20010701 | 
| Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine. | Journal of neural transmission (Vienna, Austria : 1996) 20010101 | 
© 2019 Angene International Limited. All rights Reserved.